Exendin-4 mimetics exenatide and lixisenatide are short-acting GLP-1 receptor agonists with high plasma concentrations at the time of meal intake, primarily targeting gastric emptying and postprandial hyperglycemia. The gene discussed is GLP1R; the disease is Hyperglycemia.